Commission Implementing Regulation (EU) 2023/114 [Commission Implementing Regulation (EU) 2023/114 of 16 January 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, buprofezin, cyflufenamid, fluazinam, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metiram, metsulfuron-methyl, phosphane and pyraclostrobin (OJ L 15, 17.1.2023, p. 9, ELI: http://data.europa.eu/eli/reg_impl/2023/114/oj).] extended the approval period of the active substances buprofezin, mecoprop-P and pyraclostrobin until 31 January 2024, of the active substances fluazinam, flutolanil and mepiquat until 29 February 2024, of the active substance benzovindiflupyr until 2 March 2024 and of the active substances cyflufenamid, lambda-cyhalothrin, metsulfuron-methyl and phosphane until 31 March 2024.
Recital 3, Regulation (EU) 2024/324
In forcesince 19 Jan 2024